Login to Your Account

BioMarin Gains Asthma Drug, Sales Force Via Ascent Buyout

By Karen Pihl-Carey

Thursday, April 22, 2004
Transforming itself from a development company to one that has its own sales force, BioMarin Pharmaceutical Inc. signed definitive plans to acquire Ascent Pediatrics Inc. for $175 million in cash and stock payments over five years. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription